EVLVHIGH SIGNALREGULATORY10-K

EVLV has completed a restatement process related to sales practice irregularities, with the company removing all prior restatement language and explanatory notes from its latest filing.

The removal of restatement-related language suggests EVLV has moved past its revenue recognition issues that triggered an independent investigation in 2024. However, the substantial increase in current liabilities alongside revenue growth indicates the company may still be managing financial complexities from this transition period.

Comparing 2026-03-10 vs 2025-04-28View on EDGAR →
FINANCIAL ANALYSIS

EVLV showed strong operational momentum with revenue growing substantially and operating losses meaningfully reduced year-over-year. The company improved its cash position while reducing inventory levels and capital expenditures, suggesting better working capital management. However, the notable increase in current liabilities warrants attention as it outpaced the growth in current assets, potentially indicating ongoing financial adjustments related to the company's recent operational changes.

FINANCIAL STATEMENT CHANGES
Inventory
Balance Sheet
-45.1%
$17.0M→$9.3M

Inventory drawn down 45.1% — strong sell-through or deliberate destocking; watch for supply constraints.

Capital Expenditure
Cash Flow
-43.9%
$6.6M→$3.7M

Capex reduced 43.9% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Operating Income
P&L
+41.1%
-$82.3M→-$48.5M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Revenue
P&L
+40.5%
$103.9M→$145.9M

Strong top-line growth of 40.5% — accelerating demand or successful expansion into new markets.

Net Income
P&L
+38.7%
-$54.0M→-$33.1M

Net income grew 38.7% — bottom-line growth signals improving overall business health.

Cash & Equivalents
Balance Sheet
+32.8%
$37.0M→$49.1M

Cash position surged 32.8% — strong cash generation or capital raise providing significant financial cushion.

Current Liabilities
Balance Sheet
+27.2%
$96.7M→$123.0M

Current liabilities rose 27.2% — increased short-term obligations, watch current ratio.

Gross Profit
P&L
+27%
$59.3M→$75.3M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Current Assets
Balance Sheet
+24.6%
$121.4M→$151.3M

Current assets grew 24.6% — improving short-term liquidity or inventory/receivables build.

Total Liabilities
Balance Sheet
+23%
$150.4M→$185.0M

Liabilities increased 23% — monitor debt-to-equity ratio and interest coverage.

LANGUAGE CHANGES
NEW — 2026-03-10
PRIOR — 2025-04-28
ADDED
As of March 3, 2026, the registrant had 179,350,739 shares of Class A common stock, par value $0.0001 per share, outstanding.
BUSINESS Company Overview Evolv Technologies Holdings, Inc., a Delaware corporation formed in 2021 ( we, us, our, the Company and Evolv ) is a leading security technology company pioneering Artificial Intelligence ( AI )-powered screening solutions designed to help create safer environments while maintaining efficient visitor flow and a positive visitor experience.
We serve customers across a range of end markets, including education, healthcare, sports, live entertainment, tourist attractions, houses of worship, and industrial workplaces.
Our goal is to help facility operators address escalating gun violence, mass shootings and terrorist attacks while maintaining a positive visitor experience.
Our solutions are delivered through a Security-as-a-Service model that integrates our proprietary sensor platform and AI-powered software, cloud connectivity, and ongoing services.
+7 more — sign up free →
REMOVED
As of April 21, 2025, the registrant had 163,470,325 shares of Class A common stock, par value $0.0001 per share, outstanding.
EXPLANATORY NOTE Introduction As previously announced in the Current Report on Form 8-K filed with the U.S.
Securities and Exchange Commission (the SEC ) on October 25, 2024, the Board of Directors (the Board ) of Evolv Technologies Holdings, Inc.
As a result of these misstatements, the Company is restating certain financial information for the Non-Reliance Periods.
All restated financial information is included in this Annual Report on Form 10-K for the year ended December 31, 2024 (the Form 10-K ), and we have not filed, and do not intend to file, amendments to any of our filings that we have previously filed with the SEC.
+7 more — sign up free →
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →